1. Home
  2. WHG vs SLGL Comparison

WHG vs SLGL Comparison

Compare WHG & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westwood Holdings Group Inc

WHG

Westwood Holdings Group Inc

SELL

Current Price

$19.13

Market Cap

185.2M

Sector

Finance

ML Signal

SELL

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

SELL

Current Price

$68.70

Market Cap

218.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
WHG
SLGL
Founded
1983
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.2M
218.9M
IPO Year
2002
2016

Fundamental Metrics

Financial Performance
Metric
WHG
SLGL
Price
$19.13
$68.70
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $152.50
AVG Volume (30 Days)
13.8K
★ 33.4K
Earning Date
10-29-2026
11-19-2026
Dividend Yield
★ 3.13%
N/A
EPS Growth
★ 203.85
N/A
EPS
★ 0.25
N/A
Revenue
★ $97,762,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$76.56
★ N/A
Revenue Growth
★ 3.21
N/A
52 Week Low
$14.70
$28.81
52 Week High
$20.97
$97.97

Technical Indicators

Market Signals
Indicator
WHG
SLGL
Relative Strength Index (RSI) 50.89 47.31
Support Level $18.58 $68.81
Resistance Level $20.13 $80.53
Average True Range (ATR) 0.52 4.30
MACD 0.01 0.03
Stochastic Oscillator 53.15 17.72

Price Performance

Historical Comparison
WHG
SLGL

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its Advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States, and also has its presence in Canada.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Share on Social Networks: